Adaptogens for Women - ashwagandha, rhodiola, maca 2026

Ashwagandha, rhodiola, and maca are three plants that women most often turn to for support with stress, fatigue, and menopausal symptoms. Each works differently and each has a different level of evidence. Ashwagandha reduced cortisol levels by 27.9% compared to 7.9% in the placebo group in a randomized study of 64 participants (Indian Journal of Psychological Medicine, 2012). Rhodiola reduced fatigue after 28 days in individuals with burnout syndrome, while maca has the weakest research backing of the three, although it is marketed as a women's herb. This guide provides dosages, timing for intake during the cycle, and contraindications, with particular attention to pregnancy and breastfeeding. For each claim, we clearly state whether it is backed by clinical research or just tradition and manufacturer materials.

KEY INFORMATION
• Ashwagandha has the strongest evidence: 300-600 mg of standardized extract daily reduces cortisol and stress scale scores (Chandrasekhar 2012, Indian J Psychol Med).
• Rhodiola works the fastest: 576 mg of SHR-5 extract daily reduced fatigue after 28 days in individuals with burnout syndrome (Olsson 2009, Planta Medica).
• Maca has the weakest backing: a systematic review included four studies and deemed the evidence too limited to draw conclusions (Shin 2010, BMC Complement Altern Med).
• None of these herbs should be used during pregnancy or breastfeeding, and there are no studies on rhodiola and maca in these groups.
• The full effect on the stress axis requires 8-12 weeks; assessment after two weeks is not substantiated.

What are adaptogens and how do they work in women?

Adaptogens are plants attributed with increasing the body's nonspecific resistance to stress. The concept was introduced by Soviet pharmacologists Brekhman and Dardymov in a 1969 paper in the Annual Review of Pharmacology (Annual Review of Pharmacology, 1969). A common denominator in contemporary descriptions is the impact on the hypothalamic-pituitary-adrenal axis.

The review by Panossian and Wikman from 2010 gathered data on the molecular mechanisms behind this effect. The authors link the protective action of adaptogens to the regulation of the HPA axis and stress response mediators, including heat shock proteins from the HSP70 family, JNK1 kinase, transcription factor DAF-16, cortisol, and nitric oxide (Pharmaceuticals, 2010). Most of this data comes from animal studies and neuronal cell cultures, not from clinical trials.

There is a claim that women respond to psychosocial stress with a cortisol spike that is several dozen percent stronger than that of men. Measurements do not confirm this. In the study by Kirschbaum et al. from 1999, in which 81 individuals underwent the Trier Social Stress Test, men had a higher ACTH response than any of the three groups of women, and free cortisol in saliva followed this sequence: luteal phase equal to men, above the follicular phase, and above women using oral contraceptives (Psychosomatic Medicine, 1999).

The practical conclusion is different from what the popular version suggests. It is not that the female body produces more cortisol, but that its response changes depending on the phase of the cycle and the use of hormonal contraception. Therefore, the same dose of adaptogen may produce different sensations in different weeks of the cycle, and assessing effectiveness makes sense only after a full two or three cycles. We elaborate on the stress axis mechanism in a separate text about this, how adaptogens affect the HPA axis.

What does ashwagandha provide for women according to research?

Ashwagandha has the strongest backing of the three. Chandrasekhar et al. studied 64 individuals with chronic stress: for 60 days, they took 300 mg of root extract twice daily. Serum cortisol dropped by 27.9% compared to 7.9% in the placebo group, and the Perceived Stress Scale score decreased by 44.0% compared to 5.5% (Indian Journal of Psychological Medicine, 2012).

This same study describes the raw material in more detail than most studies in this field. It was the KSM-66 extract from Ixoreal Biomed, standardized to no less than 5% withanolides measured by HPLC. The standardization values provided by other manufacturers, for example, no less than 10% withanolide glycosides for Sensoril, come from commercial specifications and measure something different, so they cannot be directly compared to these 5%.

The second area is sleep. A meta-analysis by Cheah et al. from 2021 included five randomized studies and 400 participants, and the overall effect on sleep was -0.59 in standardized mean difference, with a confidence interval from -0.75 to -0.42 (PLoS One, 2021). The authors describe it as small but significant, noting that it was more pronounced in individuals with diagnosed insomnia, at a dose of 600 mg daily and after at least eight weeks.

The third area is the thyroid. In the study by Sharma et al. from 2018, 50 individuals aged 18-50 with subclinical hypothyroidism took 600 mg of extract daily for eight weeks, and TSH, T3, and T4 values significantly improved compared to placebo (Journal of Alternative and Complementary Medicine, 2018). This can be beneficial in hypothyroidism, but the same effect is problematic in hyperthyroidism.

What the studies did not show, but is often attributed to them: none of the above evaluated the menstrual cycle, menstrual pain, or PMS severity. The claim that ashwagandha regulates the cycle has no support in clinical trials today and should be treated as such.

When does rhodiola help, and when does it harm?

Rhodiola rosea, or golden root, works the fastest of the three, and the best-documented indication is fatigue. Olsson et al. administered 576 mg of SHR-5 extract daily for 28 days to 60 individuals with fatigue syndrome. Compared to placebo, there were improvements in the Pines burnout scale and several attention indicators in the Conners computer test, and the cortisol response upon awakening differed between groups (Planta Medica, 2009).

In terms of mood, the picture is much weaker. Mao et al. in 2015 compared rhodiola with sertraline and placebo in 57 individuals with mild to moderate depression over 12 weeks. The decreases in depression scale scores were small and statistically insignificant, and the differences between groups did not reach significance. Sertraline reduced the Hamilton scale score by 8.2 points, rhodiola by 5.1, and placebo by 4.6 (Phytomedicine, 2015).

This same study is the source of a number often misquoted. Adverse effects were reported by 63.2% of those on sertraline, 30.0% on rhodiola, and 16.7% on placebo. This is about a twofold difference compared to the drug, not sixfold as some reports state. The authors' conclusion is cautious: rhodiola worked weaker than sertraline but was better tolerated, so the benefit-risk balance may be more favorable for it in mild cases.

Rhodiola does not replace treatment for a depressive episode. It should not be used in bipolar affective disorder, uncontrolled hypertension, or hyperthyroidism, and in individuals with heightened anxiety, its stimulating effect may exacerbate symptoms in the initial days. The dose is taken in the morning or before noon, no later than 2 PM, as it can disrupt sleep if taken later. We elaborate on dosing details in a separate text about the properties of rhodiola.

Does maca change hormonal balance?

In the available studies, it did not. Gonzales et al. administered 1500 or 3000 mg of gelatinized maca root for 12 weeks and noted an improvement in perceived sexual desire from the eighth week, with no differences in testosterone and estradiol levels compared to placebo (Andrologia, 2002). However, this study was conducted in men aged 21-56, so transferring its conclusions to women requires caution.

Data for women comes from one small trial. Brooks et al. included 14 postmenopausal women who took 3.5 g of powdered maca in an alternating regimen with placebo for six weeks. Estradiol, FSH, LH, and sex hormone-binding globulin levels did not change, while the Greene scale showed improvements in psychological symptom subscales, namely anxiety and low mood, as well as sexual dysfunction indicators (Menopause, 2008).

It's worth noting what is missing from this result. The improvement concerned psychological symptoms and the sexual sphere, not hot flashes. The popular claim that maca reduces hot flashes in 60-80% of women does not come from any of these studies, and we were unable to identify any publication that supports it.

The entirety of the evidence is summarized in a systematic review by Shin et al. from 2010. It included four randomized studies and found limited evidence of maca's effectiveness in sexual function disorders, with the authors stating directly that the number of trials, total sample size, and their methodological quality are too small to draw definitive conclusions (BMC Complementary and Alternative Medicine, 2010). Therefore, maca is the least documented option among the three, despite being marketed most often as a "female" plant.

Which adaptogen to choose for which symptom?

The choice is based on the dominant symptom and how strong the evidence is for a given indication. For stress and sleep, the first choice is ashwagandha, as only it has meta-analyses. For fatigue and decreased drive, rhodiola is more sensible, as it acts faster. Maca remains an option for reduced libido and perimenopausal symptoms, with the understanding that it has the least data behind it.

The table also clarifies one thing that marketing obscures: the columns are not equivalent. Ashwagandha has evidence from meta-analyses, rhodiola from individual trials, and maca from a review that rated itself as insufficient. So when three plants sit side by side on a shelf at the same price, it does not mean that they have the same evidence behind them.

How long should you take adaptogens?

The horizon is set by the studies themselves. Rhodiola showed measurable effects after 28 days, ashwagandha after eight weeks or more, and maca in trials lasting from six to twelve weeks. An assessment after seven or fourteen days does not correspond to any of these protocols and usually leads to premature discontinuation.

A reasonable twelve-week scheme is divided into three stages. For the first two weeks, half the target dose is taken to assess stomach tolerance and catch any adverse reactions. From the third to the eighth week, the full dose is administered. The last four weeks serve to stabilize and assess whether the effect is sufficient to continue.

Introduce one ingredient at a time, with a gap of one or two weeks. With three plants introduced on the same day, it is impossible to determine which one is responsible for the improvement and which for stomach discomfort. This is the simplest way to know anything certain about your own reaction after three months.

Time must be considered alongside the dose, as one does not work without the other. Salve et al. divided 60 stressed adults into three groups: 125 mg of ashwagandha twice daily, 300 mg twice daily, and a placebo, and monitored them for eight weeks. The stress scale results and cortisol levels decreased with both doses, but at 600 mg daily, the significance level was higher (Cureus, 2019). Eight weeks at a dose below the studied threshold will not replace eight weeks at the proper dose.

There is practically no data on use longer than a few months. The American NCCIH states that ashwagandha may be safe for short-term use, up to about three months, and there is a lack of information to assess longer periods (NCCIH, 2023). Practiced breaks, such as one month after every three months, are a precautionary measure rather than a recommendation based on research.

Should adaptogens be combined with CBD?

There is no study that has tested such a combination, so the answer is based on the profiles of both groups separately. Adaptogens are described as acting through the HPA axis and stress response mediators, while cannabidiol acts through the endocannabinoid system and 5-HT1A receptors. These pathways do not overlap, but the mere lack of overlap is not evidence of synergy.

The most frequently cited work on CBD, sleep, and anxiety is a retrospective case series by Shannon et al. from 2019. The documentation of 72 adult patients from a psychiatric clinic who received CBD as an adjunct to treatment was reviewed. In the first month, anxiety scores decreased in 57 individuals, or 79.2%, and remained at a lower level, while sleep scores improved in 48 individuals, or 66.7%, but fluctuated over time (The Permanente Journal, 2019).

Two things need to be stated clearly about this work. It was not a randomized or placebo-controlled study, but a review of patient charts, so the strength of evidence is correspondingly lower. The authors also did not measure sleep architecture, so the frequent claim that CBD extends REM phase or deepens slow-wave sleep does not come from this source.

If you still want to compare one with the other, a sensible arrangement is simple: adaptogen in the morning or with a meal, CBD in the evening at a low dose, and observation for the first 7-10 days for excessive drowsiness. The mechanisms of both groups are compared in more detail in the text about the synergy of CBD and adaptogens.

Who should not use adaptogens?

The list is short but firm. NCCIH advises against ashwagandha for individuals before planned surgery and for those with autoimmune diseases and thyroid disorders, pointing to possible interactions with thyroid hormonal medications and noting rare but documented cases of liver damage associated with supplements containing this plant (NCCIH, 2023).

In thyroid diseases, the direction of action is known. Ashwagandha altered thyroid parameters in individuals with subclinical hypothyroidism (Sharma 2018), which can be desirable in hypothyroidism, but in hyperthyroidism and Graves' disease, it works in the wrong direction. Rhodiola, on the other hand, is discouraged in hyperthyroidism due to its stimulating effects. When treating with levothyroxine, report any changes in supplementation to your endocrinologist, as monitoring TSH then becomes necessary.

Hormone-dependent cancers require a straightforward approach. We do not know of studies that have assessed the safety of these three plants in oncology patients, either during treatment or in remission. This means that we cannot say whether they are safe or harmful. In the absence of such data, decisions should be made with the treating oncologist, not based on the description on the packaging.

Interactions with medications are poorly studied beyond what NCCIH provides for ashwagandha. If you are taking sedatives, anticoagulants, hormonal medications, or antidiabetic drugs, consult your pharmacist before adding any of these plants. The response 'data is lacking' is common here and in itself is a reason for caution.

Are adaptogens safe during pregnancy and breastfeeding?

No, and for two of the three plants, it is even impossible to say how great the risk is. NCCIH states this unequivocally for ashwagandha: it should be avoided during pregnancy and should not be used while breastfeeding (NCCIH, 2023). This recommendation is based on a lack of safety data, not on demonstrated harm.

For rhodiola and maca, the situation is even more empty. We do not know of studies evaluating their use in pregnant or breastfeeding women. We also do not know of any studies measuring whether salidroside, rosavins, or maca components pass into breast milk and in what quantities. This is not a signal that they do not pass. It means exactly that no one has checked.

The argument for traditional use of maca in the Andes appears in many studies and does not replace data. Traditional use indicates that the plant was consumed, not that its impact on pregnancy, birth weight, or infant development has been studied. A supplement in the form of a concentrated extract is, after all, a different exposure than the root in the diet.

The practical recommendation is therefore simple: during pregnancy and breastfeeding, discontinue all three. If the symptoms you wanted to address are bothersome, this is the moment to talk to your gynecologist or midwife, as in these groups, the risk of an untested substance is significantly higher than the benefit, which no one has measured.

What mistakes most often spoil the effect?

There are four common mistakes, all of which involve deviating from the research protocol: too short a duration, unmarked raw material, wrong timing of intake, and lack of any evaluation. None of these say anything about the plants themselves, only about how they are used.

Time is the number one problem. Discontinuing ashwagandha after two weeks means ending the treatment before any measurements were taken in studies. Rhodiola is an exception here, as its effect on fatigue was noted after 28 days, but even that is a month, not a week.

• A cheap powder without specified standardization does not allow you to estimate how much active substance you are taking, and the label '1000 mg' on the front usually describes the mass of the raw material, not the content of withanolides.
• Rhodiola taken in the evening disrupts falling asleep; the last dose should be taken no later than 2 PM.
• Ashwagandha without a meal containing fat is absorbed poorly, as withanolides are lipophilic, and on an empty stomach, it more often causes nausea.
• Separate maca from levothyroxine by a few hours, just like any mineral preparation, to avoid interfering with the absorption of the medication.
• Without a simple symptom diary, after eight weeks, it is impossible to distinguish improvement from the natural variability of well-being.

Evaluation is the most overlooked aspect, yet it costs the least. A weekly note with four ratings on a scale from one to ten: sleep, stress level, energy, and libido, plus a note on cycle regularity is sufficient. After three months, you have data on which the decision to continue is no longer a guess.

Podsumowanie: praktyczna strategia adaptogenna

The three plants are not equal in terms of evidence and should be selected accordingly. Ashwagandha is the first choice for stress and sleep issues, at a dose of 300-600 mg of standardized extract daily, with a real assessment horizon after eight weeks. Rhodiola is an option for fatigue and burnout, 200-576 mg in the morning, with effects visible at the earliest after a month.

Maca comes last in this order, not due to safety, but due to data. A systematic review included four studies and assessed the material as too modest to draw firm conclusions. The only trial conducted in women included fourteen participants. If you reach for maca, do so with the awareness that you are buying a premise, not evidence.

Boundaries are more important than the protocol. None of these plants are used during pregnancy or breastfeeding, and with rhodiola and maca, it is not even about known risks, but about the complete lack of studies in these groups. In cases of thyroid diseases, autoimmune diseases, and hormone-dependent cancers, the decision lies with the treating physician, as there are simply no data on which anyone else could rely.

Finally, a note about reading sources, as it is more useful in this category of products than anywhere else. Even with ashwagandha, the best-studied of the three, the authors of the systematic review by Pratte et al. stated outright that all included studies had unclear or high risk of systematic error, and the heterogeneity of methods prevented a meta-analysis (Journal of Alternative and Complementary Medicine, 2014). The same review is sometimes presented in product descriptions as a meta-analysis, which serves as stronger evidence than it actually is. Before you trust the number on the label, check the source of the study and what it actually measured.

Frequently Asked Questions

Are adaptogens safe for every woman?

No. NCCIH advises against ashwagandha during pregnancy, while breastfeeding, in cases of thyroid and autoimmune diseases, and before surgical procedures (NCCIH, 2023). There is a lack of studies on rhodiola and maca in these groups, which is also a reason for caution.

Can ashwagandha be taken during menstruation?

We do not know of any study that evaluated the use of ashwagandha in specific phases of the cycle, so there is no basis for either prohibition or promise of alleviating menstrual pain. The Chandrasekhar 2012 study measured cortisol and stress scales, not menstrual symptoms, and is sometimes cited for this thesis without basis.

When should you take rhodiola so it doesn't disrupt sleep?

In the morning or before noon, no later than 2 PM. An evening dose may cause insomnia due to its stimulating effects. In the Olsson 2009 study, 576 mg of SHR-5 extract was used daily for 28 days (Planta Medica, 2009).

Does maca affect hormones?

In available studies, it had no effect. In 14 postmenopausal women taking 3.5 g daily for six weeks, levels of estradiol, FSH, LH, and sex hormone-binding globulin remained unchanged (Brooks, Menopause, 2008). However, the sample size was very small.

Can ashwagandha, rhodiola, and maca be combined?

We do not know of any study that has tested this combination, so there is no evidence for synergy or lack thereof. If you decide to use all three ingredients, introduce them one at a time with a week or two in between, as otherwise, you won't be able to determine which one is responsible for improvement and which for discomfort.

How long does it take for adaptogens to start working?

Rhodiola showed a measurable effect on fatigue after 28 days (Olsson 2009). Ashwagandha required eight weeks or more, especially regarding sleep (Cheah, PLoS One, 2021). Maca was studied in protocols ranging from six to twelve weeks. An assessment after two weeks lacks a basis.

Is it safe to use adaptogens during pregnancy and breastfeeding?

No. Ashwagandha should be avoided during pregnancy and not used while breastfeeding (NCCIH, 2023). There are no studies for rhodiola and maca in these groups, nor are there studies checking whether their components pass into breast milk. Traditional use of maca in the Andes does not replace such data.

Can adaptogens be combined with hormonal contraception?

There is a lack of research on the interactions of adaptogens with hormonal contraception, so no one can provide a reliable answer today. For low-dose pills, consult your gynecologist. It's worth remembering that oral contraception itself alters the cortisol response to stress (Psychosomatic Medicine, 1999).

Standardized plant extracts, including ashwagandha and maca, can be found in the category plant extracts in the u Bucha store. The catalog for Rhodiola rosea as of August 10, 2026, does not include it in any form.

The article is informational and educational in nature and does not replace consultation with a doctor. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.

Author: Michał Waluk · Opublikowano: 2026-05-11 · Aktualizacja: 2026-08-10